论文信息 - Comparability Studies for Later‐Generation Products—Plant‐Made Pharmaceuticals

Comparability Studies for Later‐Generation Products—Plant‐Made Pharmaceuticals

Plant Made Pharmaceuticals (PMPs) use genetically engineered plants to express substances that may be used to treat and cure diseases such as cancer, Alzheimer's disease, diabetes, HIV, heart disease. The boundary technology nature of PMPs places it firmly into limbo in terms of social acceptability and, ultimately, economic viability. This article explores PMPs and their potential with an eye toward public response and policy actions. Keywords: plant made pharmaceuticals (PMPs); genetic engineering; regulatory system; public response

Patrick A. Stewart | P. Stewart

[1] S. Herrera. Syngenta's gaff embarrasses industry and White House , 2005, Nature Biotechnology.

[2] J. Fox. Puzzling industry response to ProdiGene fiasco , 2003, Nature Biotechnology.

[3] K. Donnelly,et al. A Quantitative Safety Assessment Model For Transgenic Protein Products Produced In Agricultural Crops , 2004 .

[4] N. Ellstrand. Going to “Great Lengths” to Prevent the Escape of Genes That Produce Specialty Chemicals1 , 2003, Plant Physiology.

[5] P. Stewart,et al. Public opinion toward the first, second, and third generations of plant biotechnology , 2005, In Vitro Cellular & Developmental Biology - Plant.

[6] P. Stewart,et al. Regulating the New Agricultural Biotechnology by Managing Innovation Diffusion , 2002 .

[7] D. Delaney,et al. Choice of Crop Species and Development of Transgenic Product Lines , 2002 .

[8] J. Larrick,et al. HUMAN PHARMACEUTICALS PRODUCED IN PLANTS , 2002 .

[9] C. Macilwain. US launches probe into sales of unapproved transgenic corn , 2005, Nature.

[10] P. Stewart,et al. Trends affecting the next generation of U.S. agricultural biotechnology: Politics, policy, and plant-made pharmaceuticals , 2005 .